Cancer Research Technology
Log in Register
Menu

Anti-SARS CoV-2-Spike [3-5C-I] monoclonal antibody

Invented at LeukoCom

Info

Catalogue Number 160700
Applications ELISA IHC Fn WB
Antigen/Gene or Protein Targets SARS CoV-2 Spike
Reactivity Virus
Relevance The global epidemic of novel coronavirus disease 2019 (COVID-19) was caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). SARS-CoV2 belongs to the Beta-coronavirus family and is able to cause severe symptoms and even death with a current fatality rate of 5%. The spike protein of SAR-CoV2 plays a key role in the receptor recognition and cell membrane fusion process of the virus to host cells through it's interaction with the receptor ACE2.
Host Mouse
Immunogen Recombinant SAR-CoV-2 spike-human Fc protein
Positive Control Recombinant SARS CoV-2-Spike-human Fc protein and recombinant SARS-CoV-2 D614G Spike active Trimer HisTag protein (10587-CV-100) R&D Systems
Subclass IgG1 kappa
Myeloma Used NS1/0
Notes Purification: Protein G purified
Cross-reactivity: Wuhan strain; VOC B.1.1.7; VOC B.1351
Species reactivity: Polyhistidin-tag

This mouse monoclonal antibody recognises SARS CoV-2-spike alone or if in complex with ACE2. Consequently it can be used as a reliable diagnostic tool to detect a wide range of SARS CoV-2 strains. As it is not competing for the ACE2-SARS Cov-2-spike binding site it can interact with its viral target even if the virus is bound to its host cell.
Research Area Virology

References

There are 0 reference entries for this reagent.

References: 0 entry

There is no reference for this reagent yet, feel free to use the button below to suggest one.

Add a reference

References: 0 entry

There is no reference for this reagent yet, feel free to use the button below to suggest one.

Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor